threonine and Deep Vein Thrombosis

threonine has been researched along with Deep Vein Thrombosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Alexander, N; de la Fuente, M; Han, X; Hofmann, L; Nieman, MT; Palczewski, K1
Gagnon, F; Kassam, I; Medina-Rivera, A; Morange, PE; Trégouët, DA; Wilson, MD; Zwingerman, N1
Haugbro, K; Sandset, PM; Skretting, G; Tjeldhorn, L1
Alessi, MC; Amouyel, P; Antoni, G; Bertrand, M; Cohen, W; Dupuy, AM; Emmerich, J; Germain, M; Lambert, JC; Lathrop, M; Letenneur, L; Lopez, LM; Morange, PE; Oudot-Mellakh, T; Saut, N; Trégouët, DA1
Choi, JR; Lee, SM; Song, KS1
Dávid, M; Habon, T; Keszthelyi, Z; Kovács, N; Losonczy, H; Nagy, A; Tóth, O1
Darwish Murad, S; de Bruijne, EL; de Maat, MP; Haagsma, EB; Janssen, HL; Leebeek, FW; Rosendaal, FR; Tanck, MW; van Hoek, B1
Bugert, P; Pabinger, I; Panzer, S; Skeate, RC; Stamer, K; Vormittag, R; Wahi, MM1

Reviews

2 review(s) available for threonine and Deep Vein Thrombosis

ArticleYear
Sex-specific effect of CPB2 Ala147Thr but not Thr325Ile variants on the risk of venous thrombosis: A comprehensive meta-analysis.
    PloS one, 2017, Volume: 12, Issue:5

    Topics: Alanine; Carboxypeptidase B2; Female; Genetic Predisposition to Disease; Humans; Isoleucine; Male; Risk Factors; Sex Factors; Threonine; Venous Thrombosis

2017
[Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Orvosi hetilap, 2005, Oct-09, Volume: 146, Issue:41

    Topics: Adult; C-Reactive Protein; Cholesterol; Cysteine; Female; Fibrin; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Pedigree; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Threonine; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor

2005

Other Studies

6 other study(ies) available for threonine and Deep Vein Thrombosis

ArticleYear
PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153.
    Blood, 2020, 11-05, Volume: 136, Issue:19

    Topics: Cell Membrane; Genome-Wide Association Study; Humans; Proline; Protein Conformation; Protein Domains; Receptors, Thrombin; Threonine; Venous Thrombosis

2020
Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis.
    Thrombosis research, 2010, Volume: 125, Issue:3

    Topics: Activated Protein C Resistance; Adult; Amino Acid Substitution; Anticoagulants; Consanguinity; DNA; Family Health; Female; Heterozygote; Homozygote; Humans; Pedigree; Protein C; Protein C Deficiency; Threonine; Venous Thrombosis

2010
KNG1 Ile581Thr and susceptibility to venous thrombosis.
    Blood, 2011, Mar-31, Volume: 117, Issue:13

    Topics: Alleles; Amino Acid Substitution; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Isoleucine; Kininogens; Male; Polymorphism, Single Nucleotide; Threonine; Venous Thrombosis

2011
Detection of an Ala601Thr mutation of plasminogen gene in 3 out of 36 Korean patients with deep vein thrombosis.
    Journal of Korean medical science, 2003, Volume: 18, Issue:2

    Topics: Adult; Aged; Alanine; Female; Humans; Korea; Male; Middle Aged; Plasminogen; Point Mutation; Risk Factors; Sequence Analysis, DNA; Threonine; Venous Thrombosis

2003
Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Budd-Chiari Syndrome; Carboxypeptidase B2; Case-Control Studies; Female; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Polymorphism, Single Nucleotide; Portal Vein; Risk Factors; Threonine; Venous Thrombosis

2007
The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:4

    Topics: Adult; CD40 Ligand; Cohort Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Logistic Models; Lupus Coagulation Inhibitor; Male; Membrane Glycoproteins; Middle Aged; Odds Ratio; P-Selectin; Polymorphism, Single Nucleotide; Predictive Value of Tests; Proline; Risk Assessment; Risk Factors; Threonine; Thromboembolism; Thrombosis; Venous Thrombosis

2007